Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Dentsply Sirona Inc (XRAY)

  • Business News
  • Jan. 06, 2026, 21:15 UTC
  • 5
  • 1 comments

Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

AnaptysBio Inc (ANAB)

  • Business News
  • Jan. 06, 2026, 21:15 UTC
  • 4
  • 1 comments

Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

ANI Pharmaceuticals Inc. (ANIP)

  • Business News
  • Jan. 06, 2026, 21:15 UTC
  • 5
  • 1 comments

ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Twist Bioscience (TWST)

  • SEC News
  • Jan. 06, 2026, 21:14 UTC
  • 6
  • 0 comments

New Form DEF 14A - Twist Bioscience Corp Filed: 2026-01-06 AccNo: 0001581280-26-000006 Size: 7 MB

Comment Full text

Praxis Precisions Medicines Inc (PRAX)

  • SEC News
  • Jan. 06, 2026, 21:14 UTC
  • 6
  • 0 comments

New Form 424B5 - Praxis Precision Medicines, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001307 Size: 620 KB

Comment Full text

Eli Lilly and Company (LLY)

  • SEC News
  • Jan. 06, 2026, 21:14 UTC
  • 6
  • 0 comments

New Form 3 - ELI LILLY & Co Filed: 2026-01-06 AccNo: 0001724605-26-000002 Size: 682 KB

Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • SEC News
  • Jan. 06, 2026, 21:14 UTC
  • 6
  • 1 comments

Director Schenkein David P 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Integer Holdings Corp (ITGR)

  • Business News
  • Jan. 06, 2026, 21:14 UTC
  • 5
  • 1 comments

Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • SEC News
  • Jan. 06, 2026, 21:13 UTC
  • 6
  • 1 comments

Director GOLDSTEIN JOSEPH L 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Mersana Therapeutics (MRSN)

  • SEC News
  • Jan. 06, 2026, 21:12 UTC
  • 6
  • 0 comments

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001306 Size: 30 KB

Comment Full text

Avenue Therapeutics Inc (ATXI)

  • SEC News
  • Jan. 06, 2026, 21:12 UTC
  • 4
  • 0 comments

New Form SCHEDULE 13D/A - AVENUE THERAPEUTICS, INC. Filed: 2026-01-06 AccNo: 0001104659-26-001305 Size: 14 KB

Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • SEC News
  • Jan. 06, 2026, 21:12 UTC
  • 4
  • 1 comments

Director RYAN ARTHUR F 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

OPKO HEALTH (OPK)

  • Business News
  • Jan. 06, 2026, 21:12 UTC
  • 4
  • 1 comments

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • SEC News
  • Jan. 06, 2026, 21:11 UTC
  • 4
  • 1 comments

Director COLES N ANTHONY 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Regional Health Properties Inc (RHE$A)

  • SEC News
  • Jan. 06, 2026, 21:11 UTC
  • 2
  • 1 comments

(99% Neutral) Regional Health Properties, Inc. (RHE$A) Announces Regulatory Update

Comment Full text
  • Previous
  • 585
  • 586
  • 587
  • 588
  • 589
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191988)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125313)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin